rs387907313
Variant summary
Our verdict is Pathogenic. Variant got 17 ACMG points: 17P and 0B. PM1PM2PM5PP2PP3_ModeratePP5_Very_Strong
The NM_006516.4(SLC2A1):c.694C>T(p.Arg232Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,884 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R232H) has been classified as Likely pathogenic.
Frequency
Consequence
NM_006516.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 17 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC2A1 | NM_006516.4 | c.694C>T | p.Arg232Cys | missense_variant | 6/10 | ENST00000426263.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC2A1 | ENST00000426263.10 | c.694C>T | p.Arg232Cys | missense_variant | 6/10 | 1 | NM_006516.4 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251426Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135894
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461884Hom.: 0 Cov.: 33 AF XY: 0.00000138 AC XY: 1AN XY: 727244
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | May 15, 2014 | p.Arg232Cys (CGC>TGC): c.694 C>T in exon 6 of the SLC2A1 gene (NM_006516.2)The R232C mutation in the SLC2A1 gene was previously reported in multiple individuals from one family with idiopathic generalized epilepsy, predominantly characterized by absence seizures, and it was also detected in several unaffected family members consistent with reduced penetrance for this mutation (Striano et al., 2012). Functional studies indicate this mutation mildly impairs glucose transport (Striano et al., 2012). R232C was not detected in 846 normal control individuals, and the NHLBI ESP Exome Variant Project has not identified it in approximately 6,500 individuals of European or African American ethnicity (Striano et al., 2012; Exome Variant Project, 2014). The R232C mutation results in a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties, and in silico algorithms predict R232C may be damaging to protein structure and function. It alters a highly conserved residue in the cytoplasmic loop between the sixth and seventh transmembrane domains, and missense mutations have been reported at other residues in this region of the protein in association with GLUT1 deficiency (Leen et al., 2010). The variant is found in EPILEPSY,CHILD-EPI panel(s). - |
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2021 | - - |
Encephalopathy due to GLUT1 deficiency Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
GLUT1 deficiency syndrome 1, autosomal recessive Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 15, 2023 | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects SLC2A1 function (PMID: 22282645). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC2A1 protein function. ClinVar contains an entry for this variant (Variation ID: 37301). This missense change has been observed in individual(s) with idiopathic generalized epilepsy (PMID: 22282645; Invitae). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs387907313, gnomAD 0.0009%). This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 232 of the SLC2A1 protein (p.Arg232Cys). - |
Epilepsy, idiopathic generalized, susceptibility to, 12 Other:1
risk factor, no assertion criteria provided | literature only | OMIM | Feb 21, 2012 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at